comparison of glp-1 agonists History glucagon-like peptide-1 receptor Science Behind GLP 1 GIP

393 As a result, GLP-1RAs could mitigate the detrimental effects of hyperlipidemia-induced skeletal defects, leading to an improved prognosis in individuals with OA

doi: 10.1152/ajpendo.00446.2012 38 KooijmanSWangYParlevlietETBoonMREdelschaapDSnaterseGet al

Nissen says, since we know that these incretin-based therapies affect a lot more than just cardiovascular death, MI and stroke

Brandt SJ, Mller TD, DiMarchi RD, et al

Nevertheless, tirzepatide use seemed to be associated with a higher risk (RR 1.97, 95% CI 1.143.42, p = 0.558) [129]

doi: 10.2337/DIABETES.51.2007.S434 61 DahlKBrooksAAlmazediFHoffSTBoschiniCBkdalTA